114 related articles for article (PubMed ID: 31042379)
1. Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias.
Stanek M; Picard LP; Schmidt MF; Kaindl JM; Hübner H; Bouvier M; Weikert D; Gmeiner P
J Med Chem; 2019 May; 62(10):5111-5131. PubMed ID: 31042379
[TBL] [Abstract][Full Text] [Related]
2. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
3.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
4. Gα
Wang J; Hanada K; Staus DP; Makara MA; Dahal GR; Chen Q; Ahles A; Engelhardt S; Rockman HA
Nat Commun; 2017 Nov; 8(1):1706. PubMed ID: 29167435
[TBL] [Abstract][Full Text] [Related]
5. Unique Positive Cooperativity Between the
Pani B; Ahn S; Rambarat PK; Vege S; Kahsai AW; Liu A; Valan BN; Staus DP; Costa T; Lefkowitz RJ
Mol Pharmacol; 2021 Nov; 100(5):513-525. PubMed ID: 34580163
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
Gimenez LE; Baameur F; Vayttaden SJ; Clark RB
Mol Pharmacol; 2015 Jun; 87(6):954-64. PubMed ID: 25784721
[TBL] [Abstract][Full Text] [Related]
7. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.
Littmann T; Göttle M; Reinartz MT; Kälble S; Wainer IW; Ozawa T; Seifert R
J Pharmacol Exp Ther; 2015 Nov; 355(2):183-90. PubMed ID: 26306764
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
10. β-arrestin-biased agonism of β-adrenergic receptor regulates Dicer-mediated microRNA maturation to promote cardioprotective signaling.
Teoh JP; Bayoumi AS; Aonuma T; Xu Y; Johnson JA; Su H; Weintraub NL; Tang Y; Kim IM
J Mol Cell Cardiol; 2018 May; 118():225-236. PubMed ID: 29627294
[TBL] [Abstract][Full Text] [Related]
11. The β-Blocker Carvedilol and Related Aryloxypropanolamines Promote ERK1/2 Phosphorylation in HEK293 Cells with
Hamed O; Jayasinghe V; Giembycz MA
J Pharmacol Exp Ther; 2024 Jan; 388(2):688-700. PubMed ID: 38129128
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists.
Furse KE; Lybrand TP
J Med Chem; 2003 Oct; 46(21):4450-62. PubMed ID: 14521408
[TBL] [Abstract][Full Text] [Related]
13. Discovery of β-arrestin-biased β
Woo AY; Ge XY; Pan L; Xing G; Mo YM; Xing RJ; Li XR; Zhang YY; Wainer IW; Cheng MS; Xiao RP
Acta Pharmacol Sin; 2019 Aug; 40(8):1095-1105. PubMed ID: 30643208
[TBL] [Abstract][Full Text] [Related]
14. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into binding specificity, efficacy and bias of a β
Masureel M; Zou Y; Picard LP; van der Westhuizen E; Mahoney JP; Rodrigues JPGLM; Mildorf TJ; Dror RO; Shaw DE; Bouvier M; Pardon E; Steyaert J; Sunahara RK; Weis WI; Zhang C; Kobilka BK
Nat Chem Biol; 2018 Nov; 14(11):1059-1066. PubMed ID: 30327561
[TBL] [Abstract][Full Text] [Related]
16. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
Nials AT; Sumner MJ; Johnson M; Coleman RA
Br J Pharmacol; 1993 Feb; 108(2):507-15. PubMed ID: 8095419
[TBL] [Abstract][Full Text] [Related]
17. Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists.
Swaminath G; Deupi X; Lee TW; Zhu W; Thian FS; Kobilka TS; Kobilka B
J Biol Chem; 2005 Jun; 280(23):22165-71. PubMed ID: 15817484
[TBL] [Abstract][Full Text] [Related]
18. [β-arrestin2 recruitment by β-adrenergic receptor agonists and antagonists].
Wang YR; Cheng DQ; Ma L; Liu X
Sheng Li Xue Bao; 2022 Dec; 74(6):993-1004. PubMed ID: 36594387
[TBL] [Abstract][Full Text] [Related]
19. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
Warne T; Moukhametzianov R; Baker JG; Nehmé R; Edwards PC; Leslie AG; Schertler GF; Tate CG
Nature; 2011 Jan; 469(7329):241-4. PubMed ID: 21228877
[TBL] [Abstract][Full Text] [Related]
20. Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
Allen MJ; Coleman RA
Eur J Pharmacol; 1995 Feb; 274(1-3):7-15. PubMed ID: 7768283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
